Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07048496

Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support

Led by Abramson Cancer Center at Penn Medicine · Updated on 2026-05-13

50

Participants Needed

1

Research Sites

61 weeks

Total Duration

On this page

Sponsors

A

Abramson Cancer Center at Penn Medicine

Lead Sponsor

B

Blue Cross Blue Shield

Collaborating Sponsor

AI-Summary

What this Trial Is About

The proposed project will have two separate cohorts. The first will be to perform a more in-depth qualitative assessment of the barriers and facilitators for treatment compliance for non-muscle invasive bladder cancer. The second arm will be to create and test a BCG at home program. Participants in the second cohort will be enrolled in a conversational agent to measure patient symptoms and quality of life and improve self-efficacy.

CONDITIONS

Official Title

Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Completed intravesical treatment for non-muscle invasive bladder cancer within the past year (Cohort 1 patients)
  • Age 18 years or older with more than 2 years experience delivering BCG (Cohort 1 key stakeholders)
  • Age 18 years or older
  • Diagnosed with non-muscle invasive bladder cancer and prescribed BCG for initial therapy (Cohort 2)
Not Eligible

You will not qualify if you...

  • Inability to provide informed consent
  • Inability to undergo catheterization (such as history of urethral stricture) (Cohort 2)
  • Inability to receive BCG therapy (such as previous reaction to BCG) (Cohort 2)
  • No access to mobile phone (Cohort 2)
  • Inability to respond to written conversations in English (Cohort 2)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Abramson Cancer Center

Philadelphia, Pennsylvania, United States, 19104

Actively Recruiting

Loading map...

Research Team

D

Daniel Lee, PI, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support | DecenTrialz